With the Migraine Research Foundation reporting that migraine headaches affect 38 million adults and children in the U.S. (more than asthma and diabetes put together), it's not surprising that Dr. Matthisen sees a lot of headache sufferers in our Anchorage office. Eventhough some people choose to relieve migraine pain with medications, chiropractic is a great, all-natural choice that consistently produces positive results.
For instance, one study published in the Journal of Manipulative and Physiological Therapeutics involved 127 participants ranging in age from 10 to 70-years-old who struggled with frequent (at least monthly) headaches. Each subject engaged in up to 16 chiropractic sessions. The subjects noted that their headache frequency, duration, and disability two months before the treatments began, during the duration of the sessions (which was two months), and two months post-treatment.
What the authors discovered is that chiropractic adjustments reduced the frequency, duration, and disability of the migraine pain when compared with the control subjects who didn't receive chiropractic. In addition, this allowed them to take less medication for the pain, providing them an all-natural solution for a chronic problem.
Another study found that a combination of chiropractic and neck massage reduced migraine pain almost 68%.
If you have migraine headaches and are looking for help, call Dr. Matthisen today and request an appointment in our Anchorage chiropractic office. We'll do what we can to help you become pain-free!
Research Papers
Migraine Fact Sheet. Migraine Research Foundation. Retrieved from http://www.migraineresearchfoundation.org/fact-sheet.html on November 2, 2015
Noudeh Y et al. (2012). Reduction of current migraine headache pain following neck massage and spinal manipulation. International Journal of Therapeutic Massage & Bodywork;5(1):5-13
Tuchin P et al. (2000, February). A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. Journal of Manipulative and Physiological Therapeutics;23(2):91-5